ASFA
ABBV icon

All Season Financial Advisors’s AbbVie ABBV Stock Holding History

All Season Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,672
Closed -$585K – 96
2023
Q1 		$585K Buy
3,672
+1,139
+45% +$174K 0.53% 47
2022
Q4 		$409K Sell
2,533
-9
-0.4% -$1.38K 0.36% 67
2022
Q3 		$341K Sell
2,542
-24
-0.9% -$3.44K 0.37% 54
2022
Q2 		$393K Sell
2,566
-555
-18% -$84.8K 0.34% 62
2022
Q1 		$506K Sell
3,121
-73
-2% -$10.6K 0.36% 60
2021
Q4 		$432K Buy
+3,194
New +$377K 0.3% 74

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

All Season Financial Advisors's ABBV Position: Q2 2023 in Review

All Season Financial Advisors sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 3,672 shares — an estimated $585K sold.

All Season Financial Advisors first reported a position in ABBV in Q4 2021 and held it in 6 quarters. The position peaked at $585K in Q1 2023. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • All Season Financial Advisors reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • All Season Financial Advisors sold 3,672 AbbVie shares in Q2 2023, an estimated $585K.
  • All Season Financial Advisors first reported a position in AbbVie in Q4 2021 and held it in 6 quarters.
  • All Season Financial Advisors's AbbVie position peaked at $585K in Q1 2023.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on All Season Financial Advisors's 13F filing for Q2 2023, filed 25 Jul 2023.